Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next couple of years…
Wales, November 16, 2018: ADC Biotechnology (ADC Bio), announces that it has secured additional funding of £2.5 million from existing investors and…
Much needed more efficient manufacturing processes aren’t being completed by pharma for ADCs Wales, June 06, 2018: ADC Biotechnology (ADC Bio)…
Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach Wales, April 25, 2018: ADC Biotechnology (ADC Bio), announces that it has secured £1.14…